MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Servotronics (NYSE American: SVT) for possible breaches of fiduciary duty and other violations of law in its transaction with TransDigm.
MILWAUKEE, May 27, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Zscaler (NASDAQ: ZS). The investigation results from inaccurate statements Zscaler may have ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating E2open (NYSE: ETWO) for possible breaches of fiduciary duty and other violations of law in its transaction with WiseTech. Click here to ...
Shareholder Alert: The Ademi Firm Continues to Investigate Whether Sapiens International Corporation Is Obtaining a Fair Price for Its Public Shareholders The Ademi Firm is investigating Sapiens ...
MILWAUKEE, Dec. 30, 2025 /PRNewswire/ -- The Ademi Firm is investigating ON24 (NYSE: ONTF) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Aerovate (Nasdaq: AVTE) for possible breaches of fiduciary duty and other violations of law in its transaction with Jade. Click here to learn how ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating TEGNA (NYSE: TEGNA) for possible breaches of fiduciary duty and other violations of law in its going-private transaction. Click here to ...
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Duckhorn (NYSE: NAPA) for possible breaches of fiduciary duty and other violations of law in its transaction with Butterfly Equity. Click here to ...
MILWAUKEE, March 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Day One (NASDAQ: DAWN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE, March 9, 2026 /PRNewswire/ -- Ademi LLP is investigating Talkspace (NASDAQ: TALK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Inozyme (Nasdaq: INZY) for possible breaches of fiduciary duty and other violations of law in its transaction with BioMarin. Click here to ...